Search research articles
Contact Us
Filters
Showing results (371-380 of 453) with videos related to
Page
of 46
Sort By:
Frontiers in Cellular Neuroscience
|
November 2, 2020
PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer's Disease
Nabil Itzi Luna-Viramontes, B Berenice Campa-Córdoba, Miguel Ángel Ontiveros-Torres, et al.
American Heart Journal
|
May 29, 2000
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial
E J Topol, J D Easton, P Amarenco, et al.
Journal of Alzheimer'S Disease : JAD
|
October 29, 2019
Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease
Bjoern O Schelter, Helen Shiells, Thomas C Baddeley, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2021
Tau Protein Phosphorylated at Threonine-231 is Expressed Abundantly in the Cerebellum in Prion Encephalopathies
Vıctor Manuel Gómez-López, Amparo Viramontes-Pintos, Miguel Ángel Ontiveros-Torres, et al.
Behavioural Pharmacology
|
March 14, 2015
Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models
Valeria Melis, Mandy Magbagbeolu, Janet E Rickard, et al.
The Journal of Clinical Investigation
|
August 5, 2025
The protein deacetylase SIRT2 exerts metabolic control over adaptive β cell proliferation
Matthew Wortham, Bastian Ramms, Chun Zeng, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 20, 2014
Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration
V Melis, C Zabke, K Stamer, et al.
Frontiers in Neurology
|
April 29, 2021
Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection
Mar Pacheco-Herrero, Luis O Soto-Rojas, Charles R Harrington, et al.
Lancet (London, England)
|
November 20, 2016
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Serge Gauthier, Howard H Feldman, Lon S Schneider, et al.
Arthritis and Rheumatism
|
December 21, 2011
Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?
M Kristen Demoruelle, Michael H Weisman, Philip L Simonian, et al.
Page
of 46
Search research articles
Search
Showing results (371-380 of 453) with videos related to
Sort By:
Page
of 46
Frontiers in Cellular Neuroscience
|
November 2, 2020
PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer's Disease
Nabil Itzi Luna-Viramontes, B Berenice Campa-Córdoba, Miguel Ángel Ontiveros-Torres, et al.
American Heart Journal
|
May 29, 2000
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial
E J Topol, J D Easton, P Amarenco, et al.
Journal of Alzheimer'S Disease : JAD
|
October 29, 2019
Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease
Bjoern O Schelter, Helen Shiells, Thomas C Baddeley, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2021
Tau Protein Phosphorylated at Threonine-231 is Expressed Abundantly in the Cerebellum in Prion Encephalopathies
Vıctor Manuel Gómez-López, Amparo Viramontes-Pintos, Miguel Ángel Ontiveros-Torres, et al.
Behavioural Pharmacology
|
March 14, 2015
Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models
Valeria Melis, Mandy Magbagbeolu, Janet E Rickard, et al.
The Journal of Clinical Investigation
|
August 5, 2025
The protein deacetylase SIRT2 exerts metabolic control over adaptive β cell proliferation
Matthew Wortham, Bastian Ramms, Chun Zeng, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 20, 2014
Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration
V Melis, C Zabke, K Stamer, et al.
Frontiers in Neurology
|
April 29, 2021
Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection
Mar Pacheco-Herrero, Luis O Soto-Rojas, Charles R Harrington, et al.
Lancet (London, England)
|
November 20, 2016
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Serge Gauthier, Howard H Feldman, Lon S Schneider, et al.
Arthritis and Rheumatism
|
December 21, 2011
Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?
M Kristen Demoruelle, Michael H Weisman, Philip L Simonian, et al.
Page
of 46